Brief: Asit Biotech Reaches Milestone in Development of Peanut Allergy Drug

European Medical Solutions SA

12/11/2018 17:21

Nov 12 (Reuters) - ASIT BIOTECH SA  ASIT.BR :
    * ASIT BIOTECH REACHES A KEY MILESTONE IN THE DEVELOPMENT OF
A NEW
DRUG FOR PEANUT ALLERGY BY FINALIZING THE INDUSTRIALIZATION
PROCESS FOR THE MANUFACTURE OF CLINICAL BATCHES OF ITS
PNT-ASIT+™ PRODUCT CANDIDATE
    * WITH COMPLETION OF THIS CRUCIAL STAGE, COMPANY INITIATED
FINAL
PRECLINICAL DEVELOPMENTS REQUIRED BY AUTHORITIES AHEAD OF A
CLINICAL TRIAL
    * TECHNOLOGY REQUIRED FOR GMP(1)-COMPLIANT MANUFACTURE OF
BATCHES
FOR AN INITIAL PHASE I/II TRIAL IS CURRENTLY BEING TRANSFERRED

Source text for Eikon:  urn:newsml:reuters.com:*:nBw93l1rYa
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))